Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Usefulness of albuminuria as a prognostic indicator in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Niizeki T, Takeishi Y, Sasaki T, Kaneko K, Sugawara S, Watanabe T, Kubota I.

Am J Cardiol. 2013 Apr 15;111(8):1180-6. doi: 10.1016/j.amjcard.2012.12.050. Epub 2013 Jan 23.

PMID:
23351461
2.

Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ.

Am J Cardiol. 1997 Jun 15;79(12):1645-50.

PMID:
9202356
3.

Albuminuria in chronic heart failure: prevalence and prognostic importance.

Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees.

Lancet. 2009 Aug 15;374(9689):543-50. doi: 10.1016/S0140-6736(09)61378-7.

PMID:
19683640
4.

Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance.

Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kübler W, Haass M.

Circulation. 2001 May 1;103(17):2153-8.

5.

Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.

Am J Cardiol. 2009 Jan 1;103(1):73-5. doi: 10.1016/j.amjcard.2008.08.045. Epub 2008 Oct 17.

PMID:
19101233
6.

Relation of serum heat shock protein 60 level to severity and prognosis in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Niizeki T, Takeishi Y, Watanabe T, Nitobe J, Miyashita T, Miyamoto T, Kitahara T, Suzuki S, Sasaki T, Bilim O, Ishino M, Kubota I.

Am J Cardiol. 2008 Sep 1;102(5):606-10. doi: 10.1016/j.amjcard.2008.04.030. Epub 2008 Jun 12.

PMID:
18721521
7.

Heart rate variability in heart failure.

Musialik-Łydka A, Sredniawa B, Pasyk S.

Kardiol Pol. 2003 Jan;58(1):10-6.

PMID:
14502297
8.
9.

Heart rate turbulence as a predictor of cardiac mortality and arrhythmic events in patients with dilated cardiomyopathy: a prospective study.

Miwa Y, Ikeda T, Sakaki K, Miyakoshi M, Ishiguro H, Tsukada T, Abe A, Mera H, Yusu S, Yoshino H.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):788-95. doi: 10.1111/j.1540-8167.2009.01438.x. Epub 2009 Feb 27.

PMID:
19298569
10.

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L.

Am J Cardiol. 1999 Feb 1;83(3):376-82.

PMID:
10072227
11.

Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.

Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G.

Clin Sci (Lond). 2001 Aug;101(2):141-6.

PMID:
11473487
12.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
13.

Prognostic value of 6-minute walk test in stable outpatients with heart failure.

Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H, Alp N.

Tex Heart Inst J. 2007;34(2):166-9.

14.

Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure.

Miura M, Sakata Y, Miyata S, Nochioka K, Takada T, Tadaki S, Ushigome R, Yamauchi T, Takahashi J, Shimokawa H; CHART-2 Investigators.

Circ J. 2014;78(12):2890-8. Epub 2014 Oct 30.

15.

Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.

Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES.

J Hypertens. 2011 Oct;29(10):2014-23. doi: 10.1097/HJH.0b013e32834adb09.

PMID:
21873887
16.

Comparison of heart transplantation patients with ischemic and idiopathic dilated cardiomyopathy.

Gungor H, Oguz E, Ayik MF, Ertugay S, Engin C, Yagdi T, Nalbantgil S, Zoghi M, Ozbaran M.

Transplant Proc. 2011 Dec;43(10):3847-50. doi: 10.1016/j.transproceed.2011.09.073.

PMID:
22172858
17.

Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria.

Knobler H, Zornitzki T, Vered S, Oettinger M, Levy R, Caspi A, Faraggi D, Livschitz S.

J Am Coll Cardiol. 2004 Dec 7;44(11):2142-8.

18.

Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study.

Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Kohno H, Shimokawa H; CHART-2 Investigators.

Eur J Heart Fail. 2012 Apr;14(4):367-76. doi: 10.1093/eurjhf/hfs001. Epub 2012 Jan 31.

19.

Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation.

Kainuma S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Nishino M, Daimon T, Sawa Y.

J Thorac Cardiovasc Surg. 2011 Oct;142(4):783-92. doi: 10.1016/j.jtcvs.2010.11.031. Epub 2011 Mar 12.

20.

Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Parissis JT, Adamopoulos S, Venetsanou KF, Mentzikof DG, Karas SM, Kremastinos DT.

Am J Cardiol. 2000 Sep 15;86(6):707-10, A9-10.

PMID:
10980234

Supplemental Content

Support Center